Publication:
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.

dc.contributor.authorZhang, Haiying
dc.contributor.authorFreitas, Daniela
dc.contributor.authorKim, Han Sang
dc.contributor.authorFabijanic, Kristina
dc.contributor.authorLi, Zhong
dc.contributor.authorChen, Haiyan
dc.contributor.authorMark, Milica Tesic
dc.contributor.authorMolina, Henrik
dc.contributor.authorMartin, Alberto Benito
dc.contributor.authorBojmar, Linda
dc.contributor.authorFang, Justin
dc.contributor.authorRampersaud, Sham
dc.contributor.authorHoshino, Ayuko
dc.contributor.authorMatei, Irina
dc.contributor.authorKenific, Candia M
dc.contributor.authorNakajima, Miho
dc.contributor.authorMutvei, Anders Peter
dc.contributor.authorSansone, Pasquale
dc.contributor.authorBuehring, Weston
dc.contributor.authorWang, Huajuan
dc.contributor.authorJimenez, Juan Pablo
dc.contributor.authorCohen-Gould, Leona
dc.contributor.authorPaknejad, Navid
dc.contributor.authorBrendel, Matthew
dc.contributor.authorManova-Todorova, Katia
dc.contributor.authorMagalhães, Ana
dc.contributor.authorFerreira, José Alexandre
dc.contributor.authorOsório, Hugo
dc.contributor.authorSilva, André M
dc.contributor.authorMassey, Ashish
dc.contributor.authorCubillos-Ruiz, Juan R
dc.contributor.authorGalletti, Giuseppe
dc.contributor.authorGiannakakou, Paraskevi
dc.contributor.authorCuervo, Ana Maria
dc.contributor.authorBlenis, John
dc.contributor.authorSchwartz, Robert
dc.contributor.authorBrady, Mary Sue
dc.contributor.authorPeinado, Héctor
dc.contributor.authorBromberg, Jacqueline
dc.contributor.authorMatsui, Hiroshi
dc.contributor.authorReis, Celso A
dc.contributor.authorLyden, David
dc.date.accessioned2024-02-12T12:21:06Z
dc.date.available2024-02-12T12:21:06Z
dc.date.issued2018-03
dc.description.abstractThe heterogeneity of exosomal populations has hindered our understanding of their biogenesis, molecular composition, biodistribution and functions. By employing asymmetric flow field-flow fractionation (AF4), we identified two exosome subpopulations (large exosome vesicles, Exo-L, 90-120 nm; small exosome vesicles, Exo-S, 60-80 nm) and discovered an abundant population of non-membranous nanoparticles termed 'exomeres' (~35 nm). Exomere proteomic profiling revealed an enrichment in metabolic enzymes and hypoxia, microtubule and coagulation proteins as well as specific pathways, such as glycolysis and mTOR signalling. Exo-S and Exo-L contained proteins involved in endosomal function and secretion pathways, and mitotic spindle and IL-2/STAT5 signalling pathways, respectively. Exo-S, Exo-L and exomeres each had unique N-glycosylation, protein, lipid, DNA and RNA profiles and biophysical properties. These three nanoparticle subsets demonstrated diverse organ biodistribution patterns, suggesting distinct biological functions. This study demonstrates that AF4 can serve as an improved analytical tool for isolating extracellular vesicles and addressing the complexities of heterogeneous nanoparticle subpopulations.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe authors also acknowledge the Genomics Resource Core facility (WCM) for their high-quality service. The authors thank C. Ghajar and J. Weiss for feedback on the manuscript and members of the Lyden laboratory for discussions. Our study was supported by the National Cancer Institute (U01-CA169538 to D.L.), the National Institutes of Health (NIH; R01-CA169416 to D.L. and H.P.; R01-CA218513 to D.L. and H.Z.), the US Department of Defense (W81XWH-13-10249 to D.L.), W81XWH-13-1-0425 (to D.L., J.Br.), the Sohn Conference Foundation (D.L., I.M., H.P. and H.Z.), the Children’s Cancer and Blood Foundation (D.L.), The Manning Foundation (A.H. and D.L.), The Hartwell Foundation (D.L.), The Nancy C. and Daniel P. Paduano Foundation (D.L.), The Starr Cancer Consortium (H.P. and D.L.; D.L. and H.Z.), the Pediatric Oncology Experimental Therapeutic Investigator Consortium (POETIC; D.L.), the James Paduano Foundation (D.L. and H.P.), the NIH/WCM CTSC (NIH/NCATS: UL1TR00457 to H.M. and H.Z.; UL1TR002384 to D.L., H.M. and H.Z.), the Malcolm Hewitt Wiener Foundation (D.L.), the Champalimaud Foundation (D.L.), the Thompson Family Foundation (D.L., R.S.), U01-CA210240 (D.L.), the Beth Tortolani Foundation (J.Br.), the Charles and Marjorie Holloway Foundation (J.Br.), the Sussman Family Fund (J.Br.), the Lerner Foundation (J.Br.), the Breast Cancer Alliance (J.Br.), the Manhasset Women’s Coalition Against Breast Cancer (J.Br.), the National Institute on Minority Health and Health Disparities (NIMHD) of the NIH (MD007599 to H.M.), NIH/NCATS (UL1TR00457 to H.M.). C.R., A.M., D.F., A.F., A.S. and H.O. acknowledge FEDER (Fundo Europeu de Desenvolvimento Regional funds through COMPETE 2020) POCI, Portugal 2020 (NORTE-01-0145-FEDER-000029) and FCT – Fundação para a Ciência e a Tecnologia in the framework of the project ‘Institute for Research and Innovation in Health Sciences’ (POCI-01-0145-FEDER-007274) and the FCT project POCI-01-0145-FEDER-016585 (PTDC/BBB-EBI/0567/2014). The authors acknowledge FCT for grants to A.M. (SFRH/BPD/75871/2011) and A.F. (SFRH/BPD/111048/2015). D.F. acknowledges FCT (SFRH/BD/110636/2015), the BiotechHealth PhD Programme (PD/0016/2012) and the American Portuguese Biomedical Research Fund.es_ES
dc.format.number3es_ES
dc.format.page332es_ES
dc.format.volume20es_ES
dc.identifier.citationNat Cell Biol . 2018 ;20(3):332-343.es_ES
dc.identifier.doi10.1038/s41556-018-0040-4es_ES
dc.identifier.e-issn1476-4679es_ES
dc.identifier.journalNature cell biologyes_ES
dc.identifier.pmchttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931706/
dc.identifier.pubmedID29459780es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17973
dc.language.isoenges_ES
dc.publisherNature Publishing Group
dc.relation.publisherversionhttps://doi.org/ 10.1038/s41556-018-0040-4es_ES
dc.repisalud.institucionCNIOes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshNanoparticleses_ES
dc.subject.meshAnimalses_ES
dc.subject.meshBiomarkerses_ES
dc.subject.meshCell Fractionationes_ES
dc.subject.meshDNAes_ES
dc.subject.meshEnergy Metabolismes_ES
dc.subject.meshExosomeses_ES
dc.subject.meshFemalees_ES
dc.subject.meshGlycomicses_ES
dc.subject.meshGlycosylationes_ES
dc.subject.meshHCT116 Cellses_ES
dc.subject.meshHumanses_ES
dc.subject.meshMelanoma, Experimentales_ES
dc.subject.meshMetabolomicses_ES
dc.subject.meshMicees_ES
dc.subject.meshMice, Inbred C57BLes_ES
dc.subject.meshNIH 3T3 Cellses_ES
dc.subject.meshNeoplasmses_ES
dc.subject.meshPC-3 Cellses_ES
dc.subject.meshPhenotypees_ES
dc.subject.meshProteinses_ES
dc.subject.meshProteomicses_ES
dc.subject.meshRNAes_ES
dc.subject.meshSignal Transductiones_ES
dc.subject.meshTissue Distributiones_ES
dc.titleIdentification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isPublisherOfPublication301fb00e-338e-4f8c-beaa-f9d8f4fefcc0
relation.isPublisherOfPublication.latestForDiscovery301fb00e-338e-4f8c-beaa-f9d8f4fefcc0

Files